Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vistagen Therapeutics Inc (NQ: VTGN ) 3.610 -0.070 (-1.90%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 88,246 Open 3.730 Bid (Size) 3.530 (13) Ask (Size) 3.680 (1) Prev. Close 3.680 Today's Range 3.570 - 3.770 52wk Range 1.630 - 24.71 Shares Outstanding 9,362,444 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 3 Stocks Under $15 That Could Make You a Millionaire July 26, 2024 Investors looking for millionaire status in the coming years should consider three stocks under $15 that could be worth buying. Via InvestorPlace InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Awarded New Patents from Four Countries to Broaden Global PH80 IP Portfolio July 09, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Performance YTD -29.90% -29.90% 1 Month +1.12% +1.12% 3 Month -24.32% -24.32% 6 Month -31.37% -31.37% 1 Year +98.35% +98.35% More News Read More Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine July 09, 2024 From Vistagen Via Business Wire InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Receives Mental Health America’s Highest Honor June 27, 2024 Via Investor Brand Network Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year June 27, 2024 From Vistagen Via Business Wire TinyGemsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases FY 2024 Financial Report, Corporate Update June 12, 2024 Via Investor Brand Network VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024 June 12, 2024 Via InvestorPlace Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update June 11, 2024 From Vistagen Via Business Wire BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Schedules FY 2024 Financial Results Report, Conference Call June 07, 2024 Via Investor Brand Network Vistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024 June 07, 2024 From Vistagen Via Business Wire TinyGemsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) CEO to Present at Jefferies Global Healthcare Conference May 29, 2024 Via Investor Brand Network Vistagen to Present at the Jefferies Global Healthcare Conference May 29, 2024 From Vistagen Via Business Wire BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) to Present Posters at Upcoming ASCP Conference May 23, 2024 Via Investor Brand Network Vistagen to Present at the 2024 American Society of Clinical Psychopharmacology (ASCP) Conference May 23, 2024 From Vistagen Via Business Wire 3 Must-Have Penny Stocks to Boost Your 2024 Portfolio May 14, 2024 Via InvestorPlace Meme Stock Rebound: 3 Reddit Favorites Primed for a Resurgence May 13, 2024 Via InvestorPlace InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) to Present at Upcoming RBC Capital Markets Global Healthcare Conference May 07, 2024 Via Investor Brand Network Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference May 07, 2024 From Vistagen Via Business Wire InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Reports Positive PH15 Data from Pilot Study Showing Psychomotor Impairment Improvement April 25, 2024 Via Investor Brand Network Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue April 25, 2024 From Vistagen Via Business Wire 7 Stocks Under $15 Predicted to Boom in the Next 2 Years April 19, 2024 Via InvestorPlace Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027 April 09, 2024 Via InvestorPlace InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Participation at Upcoming Anxiety and Depression Association Conference April 09, 2024 Via Investor Brand Network Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference April 09, 2024 From Vistagen Via Business Wire InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Appointment of New VP of Translational Medicine April 01, 2024 Via Investor Brand Network Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
